These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 32345457

  • 1. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY, Lee Y, McLean K, Leggett D, Hodgkinson P, Fawcett J, Mott R, Stuart K, Pryor D.
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
    [Abstract] [Full Text] [Related]

  • 2. Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.
    Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, Schulenburg M, Adebahr S, Kirste S, Nestle U, Thimme R, Grosu AL, Brunner TB.
    Radiat Oncol; 2017 Jul 12; 12(1):116. PubMed ID: 28701219
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined stereotactic body radiotherapy and trans-arterial chemoembolization as initial treatment in BCLC stage B-C hepatocellular carcinoma.
    Chiang CL, Chan MKH, Yeung CSY, Ho CHM, Lee FAS, Lee VWY, Wong FCS, Blanck O.
    Strahlenther Onkol; 2019 Mar 12; 195(3):254-264. PubMed ID: 30413833
    [Abstract] [Full Text] [Related]

  • 7. Stereotactic Body Radiotherapy for Large Unresectable Hepatocellular Carcinomas - A Single Institution Phase II Study.
    Beaton L, Dunne EM, Yeung R, Rackley T, Weber B, Mar C, Yong-Hing CJ, Yoshida EM, DeVries K, Lee R, Duzenli C, Loewen SK, Liu M, Schellenberg D, Ma R.
    Clin Oncol (R Coll Radiol); 2020 Jul 12; 32(7):423-432. PubMed ID: 32093876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY, Jen YM, Lee MS, Chang LP, Chen CM, Ko KH, Lin KT, Lin JC, Chao HL, Lin CS, Su YF, Fan CY, Chang YW.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):355-61. PubMed ID: 22342300
    [Abstract] [Full Text] [Related]

  • 10. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M, Comito T, Cozzi L, Clerici E, Tozzi A, Franzese C, Navarria P, Fogliata A, Tomatis S, D'Agostino G, Iftode C, Mancosu P, Ceriani R, Torzilli G.
    J Cancer Res Clin Oncol; 2015 Jul 01; 141(7):1301-9. PubMed ID: 25644863
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4-B1: a pilot study.
    Wang F, Numata K, Takeda A, Ogushi K, Fukuda H, Nihonmatsu H, Hara K, Chuma M, Tsurugai Y, Maeda S.
    BMC Cancer; 2021 Oct 30; 21(1):1169. PubMed ID: 34717577
    [Abstract] [Full Text] [Related]

  • 13. Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy.
    Que J, Lin CH, Lin LC, Ho CH.
    Medicine (Baltimore); 2020 Aug 07; 99(32):e21561. PubMed ID: 32769898
    [Abstract] [Full Text] [Related]

  • 14. Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.
    Yeung R, Beaton L, Rackley T, Weber B, Hamm J, Lee R, Camborde M, Pearson M, Duzenli C, Loewen SK, Liu M, Ma R, Schellenberg D.
    Clin Oncol (R Coll Radiol); 2019 Jun 07; 31(6):365-373. PubMed ID: 30792051
    [Abstract] [Full Text] [Related]

  • 15. Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.
    Yamashita H, Onishi H, Matsumoto Y, Murakami N, Matsuo Y, Nomiya T, Nakagawa K, Japanese Radiological Society multi-institutional SBRT study group (JRS-SBRTSG).
    Radiat Oncol; 2014 May 10; 9():112. PubMed ID: 24886477
    [Abstract] [Full Text] [Related]

  • 16. Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease.
    Gerum S, Heinz C, Belka C, Walter F, Paprottka P, De Toni EN, Roeder F.
    Radiat Oncol; 2018 May 29; 13(1):100. PubMed ID: 29843752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.
    Lazarev S, Hardy-Abeloos C, Factor O, Rosenzweig K, Buckstein M.
    J Cancer Res Clin Oncol; 2018 Oct 29; 144(10):2077-2083. PubMed ID: 30088143
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities.
    Que JY, Lin LC, Lin KL, Lin CH, Lin YW, Yang CC.
    Radiat Oncol; 2014 May 28; 9():120. PubMed ID: 24885086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.